Management of hepatitis B virus infection after liver transplantation.

about

Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinoma.

P2860

Q38665203-CAE19381-8E1A-445B-977D-0E56377BE53D

P2860

Management of hepatitis B virus infection after liver transplantation.

Item

http://www.wikidata.org/entity/Q38635614

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Management of hepatitis B virus infection after liver transplantation.

@en

type

Item

label

Management of hepatitis B virus infection after liver transplantation.

@en

prefLabel

Management of hepatitis B virus infection after liver transplantation.

@en

P1476

Management of hepatitis B virus infection after liver transplantation.

@en

P2093

Carolina González Arjona

http://www.w3.org/2001/XMLSchema#string

Francisco Javier Rando-Muñoz

http://www.w3.org/2001/XMLSchema#string

José Mostazo Torres

http://www.w3.org/2001/XMLSchema#string

Miguel Jiménez-Pérez

http://www.w3.org/2001/XMLSchema#string

Rocío González-Grande

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome

Digitoxin metabolism by rat liver microsomes.

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review.

Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.

Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.

Prevention of hepatitis B recurrence in liver transplant patients using oral antiviral therapy without long-term hepatitis B immunoglobulin.

Utilization of hepatitis B core antibody-positive donor liver grafts

Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis.

P304

12083-12090

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V21.I42.12083

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26576093

http://www.w3.org/2001/XMLSchema#string

P932

4641126

http://www.w3.org/2001/XMLSchema#string

Management of hepatitis B virus infection after liver transplantation.

about

P2860

P2860

Management of hepatitis B virus infection after liver transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932